Novel phosphoserine phosphatase inhibitors

Area of Science:

• Biochemistry
• Neuroscience
• Enzymology

Background:

• Phosphoserine phosphatase (EC 3.1.1.3) is key in L-serine biosynthesis within the brain.
• This enzyme may also influence glycine and D-serine levels, co-agonists for the N-methyl-D-aspartate receptor.

Purpose of the Study:

• To investigate the inhibitory effects of various compounds on phosphoserine phosphatase activity.
• To explore the substrate-dependent inhibition and potential regulatory mechanisms of the enzyme.

Main Methods:

• Enzyme inhibition assays using L-phosphoserine as a substrate.
• Testing a range of potential inhibitors including sulfhydryl reagents, phosphorylcholine derivatives, and amino acid analogs.
• Investigating substrate-specific inhibition patterns for L- and D-phosphoserine.

Main Results:

• A rank order of inhibitor potency was established: p-chloromercuriphenylsulfonic acid (CMPSA) > glycerophosphorylcholine >> hexadecylphosphocholine > phosphorylcholine > N-ethylmaleimide > L-serine > fluoride > D-2-amino-3-phosphonopropionic acid (D-AP3).
• Glycerylphosphorylcholine acted as an uncompetitive inhibitor, suggesting interaction with a novel enzyme site.
• CMPSA and N-ethylmaleimide exhibited substrate-dependent inhibition, indicating potential roles in regulating enzyme multimeric state and substrate preference.

Conclusions:

• Phosphoserine phosphatase activity can be modulated by specific inhibitors, with differing potencies and mechanisms.
• Inhibitors like CMPSA and glycerylphosphorylcholine may be valuable tools for studying the enzyme's role in neuronal glycine and D-serine biosynthesis.
• The enzyme's regulation may involve substrate-dependent conformational changes or dissociation of multimeric forms.